Los Angeles, CANCT07321704Now EnrollingIRB Ready

Pilonidal Disease Clinical Trial in Los Angeles, CA

Access cutting-edge pilonidal disease treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by Yosef Nasseri, MD

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access pilonidal disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pilonidal disease treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this pilonidal disease clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Pilonidal Disease Study in Los Angeles

Pilonidal disease is a chronic condition that causes painful inflammation and infection near the top of the buttocks. Many patients require surgery, and one commonly used approach is a bilateral gluteal fasciocutaneous flap with midline closure along with placement of an extracellular matrix to support wound healing. Although effective, this surgery can still lead to wound problems such as infection, fluid collection (seroma), wound separation (dehiscence), and delayed healing. This study aims to compare two different solutions used to rinse the surgical wound before closing it. One solution is Irrisept, which contains 0.05% chlorhexidine gluconate, an antiseptic designed to reduce bacteria. The other is normal saline, which is the current standard rinse used in surgery. The goal is to determine whether using Irrisept can safely reduce post-operative infections and wound-related complications in patients undergoing flap closure and extracellular matrix implantation for pilonidal disease.

Sponsor: Yosef Nasseri, MD

Who Can Participate

Inclusion Criteria

Willing and able to provide written informed consent and to comply with the requirements of the Clinical Investigational Plan
Male or female patients aged 18 years or above
Patients scheduled for flap-based procedure for pilonidal disease with planned use of Irrisept or normal saline irrigation
Subjects who are willing and able to comply with all aspects of the treatment and evaluation schedule

Exclusion Criteria

Known allergy to contents of Irrisept (chlorhexidine gluconate)
Full-thickness ('third degree') burns
Wounds with uncontrolled clinical infection (CDC Contamination Grade 4)
Any medical condition or serious intercurrent illness that, in the opinion of the investigator, may make it undesirable for the patient to participate in the study
Currently participating or has participated in another clinical study within 30 days prior to enrollment
Pregnant or lactating women
Any subject who, at the discretion of the Investigator, is not suitable for inclusion in the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT07321704) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pilonidal Disease Treatment Options in Los Angeles, CA

If you're searching for pilonidal disease treatment options in Los Angeles, CA, this clinical trial (NCT07321704) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pilonidal disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pilonidal disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Los Angeles, CA

See all ankylosing spondylitis clinical trials recruiting in Los Angeles — not just this study.

Browse Ankylosing Spondylitis Trials in Los Angeles →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA